This paper presents an analysis of the political economy forces underlying the new conceptualisation of drug quality in the Indian pharmaceutical industry, consequent upon the process of globalisation and liberalisation and a stricter IPR regime. It examines how these forces have shaped the increasingly complex construction of drug quality, both globally and in India. It also comes up with a comprehensive multidimensional definition of drug quality incorporating a range of parameters.
